Marshall Fordyce, President and CEO at Vera Therapeutics, Inc. (VERA), sold 32,526 shares at $20.78 ($684K) on 2022-09-13, disclosed to the SEC on 2022-09-14.
Open-market sale of $684k VERA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.78 | 10,163 | $211K | 30.9% |
| 2 | $20.78 | 10,163 | $211K | 30.9% |
| 3 | $21.48 | 12,200 | $262K | 38.3% |
| Total | $21.04 avg | 32,526 | $684K | 100% |
| Filing → |
| VERA | SELL | 2026-07-09 | $2.0M | — | Filing → |
| VERA | SELL | 2026-06-24 | $702K | — | Filing → |
| VERA | SELL | 2026-05-13 | $680K | — | Filing → |